Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Course Isoniazid and Rifampin vs Isoniazid for Latent TB
NCT00397709Phase 4Terminated
- Sponsor
- Hospital Virgen de la Luz
- Start
- Mar 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifampicin in Tuberculosis (TB), sponsored by Hospital Virgen de la Luz. Started Mar 1996; status: terminated.
02
Drugs
rifampicin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00397709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397709.